Clinical Trial Update: Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial update on targeting PDGFR in recurrent malignant gliomas has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: David Piccioni, M.D., Ph.D | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2020-04-24